INVESTOR RELATIONS | ZANDER THERAPEUTICS, INC.
Entest BioMedical Inc. trades under the symbol ENTB and is the parent company of Zander Therapeutics Inc. The focus of Zander Therapeutics, Inc. is to develop small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company is specifically focused on animal therapies that address unmet medical needs. Zander is looking to increase the quality of life in animals through therapies involving small molecules, stem cell treatments and the body's own immune system. These treatments are focused in areas relating to lung, heart, circulatory system and other internal organs.